Ajanta Pharma has informed that Executive Committee of the Board of Directors has pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 fixed Thursday, 23rd June 2022 as the record date for the said corporate action.
The above information is a part of company’s filings submitted to BSE.